Innovative Trauma Care, Inc. (“iTraumaCare™”) is an early “first revenue` stage medical device company focused on developing and marketing point of injury solutions to address the common causes of preventable death in traumatic injury scenarios. Founded and incorporated in Edmonton, Canada in 2010, with U.S. headquarters in San Antonio, Texas, Innovative Trauma Care’s initial product is the iTClamp™ Hemorrhage Control System, which addresses the number one cause of preventable death in trauma scenarios – inadequately controlled bleeding. The Company is beginning to transform the field of emergency casualty care by developing, manufacturing, and commercializing point of injury solutions to treat common causes of preventable death. The Company’s initial goal is to drive adoption as fast as the current market conditions and resources allow and to capture a substantial share of the global market created in this under-exploited area of pre-hospital trauma care.
The iTClamp 50, Innovative Trauma Care’s first product, is a temporary wound closure device to control bleeding within seconds of application to an open injury. The iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. No comparable product exists in the point-of-injury space, solving an unmet medical need. Now, with market experience starting to build, the iTClamp has consistently clinically demonstrated that it can be deployed in a few seconds and stop serious bleeding from wounds in most of the targeted compressible areas of the body quickly and reliably.
iTraumaCare has launched its initial product, the iTClamp 50 into the US, Canada, Europe and selected markets in the Middle East and Africa; major market segments for the iTClamp include First Responders (Tactical Police, Fire, EMS, etc.), Military (Warfighters, Medics, Civilians in Conflict Areas, etc.), and Hospital Emergency Departments.